Results Following the Vitrification of Human Oocytes Using 2 Methodologies
NCT ID: NCT01033474
Last Updated: 2011-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
40 participants
OBSERVATIONAL
2009-12-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Null Hypothesis: The type of vitrification methodology used will not have an impact on the following:
* Survival rates
* Embryonic developmental rates
* Pregnancy and implantation rates.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oocyte Cryopreservation
NCT01232972
Evaluation of the Impact of Vitrification on Oocytes
NCT01223118
Randomized Controlled Trial Comparing Slow-freezing to Vitrification of Oocytes
NCT00777387
Effect of Oocyte Vitrification on Fertilization Rate, Embryo Quality and Development
NCT01422395
Oocyte Cryopreservation by Slow Freezing and Vitrification
NCT01223105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Frozen using an open system using a metal grid to hold the oocyte. Three to five oocytes will be frozen on the metal grid using a minute amount (\< 2-3 µls) of cryoprotectant. A top is put over the metal grid to protect the oocytes. This system has proven to be successful in limited cases in Peru. This is an open system of vitrification where the oocytes are directly plunged into liquid nitrogen. This will serve as the control.
2. Frozen in closed straws using a methodology developed by Jim Stachecki. Three to five oocytes will be frozen in ¼ cc straws. This is very similar to the method used to successfully vitrify blastocysts. This will be the experimental treatment.
Null Hypothesis: The type of vitrification methodology used will not have an impact on the following:
* Survival rates
* Embryonic developmental rates
* Pregnancy and implantation rates. Measured Outcomes The effect of vitrification technique will be measured using the appropriate statistical analysis on the following parameters.
1. Survival rates following thawing.
2. Effect of vitrification technique on how oocytes react to ICSI. The parameters have been previously defined at NCRS.
3. Normal fertilization rates, abnormal fertilization rates and rates of degeneration following ICSI.
4. Embryonic development rates. Embryos will be cultured until Day 5/6 and rate as well as quality of blastocyst will be noted.
5. Pregnancy and implantation rates following replacement in endometrial prepared recipients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
donor eggs
No interventions assigned to this group
infertile patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwest Center for Reproductive Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pranor and NW Center for Reproductive Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratorio de Reproducción Asistida
Lima, , Peru
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
555-2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.